Aromatase is the CYP19A1 enzyme responsible for converting androgens into estrogens. In particular, it converts testosterone into estradiol. In bodybuilding, this process is especially relevant during the use of exogenous testosterone, when the amount of substrate available for aromatization increases significantly.
Aromatization itself is not a problem. Estradiol is physiologically important in men and is involved in maintaining bone health, sexual function, lipid metabolism and other biological processes. Problems can arise when estradiol levels become excessively high or, conversely, fall too low.
For this reason, controlling aromatase in bodybuilding should not be understood as an attempt to suppress estrogen as much as possible. A more appropriate approach is to evaluate hormonal balance by considering testosterone and estradiol levels, symptoms, body composition and the compounds being used.
How testosterone is converted into estrogen
Aromatase catalyzes the conversion of androgens into estrogens. In the case of testosterone, the end product of this reaction is estradiol, one of the main biologically active estrogens in the body.
Aromatization occurs in a number of tissues, including:
- adipose tissue;
- the gonads;
- the central nervous system;
- bone tissue;
- and several other peripheral tissues.
For athletes, adipose tissue is particularly relevant because it is one of the important sites of peripheral aromatization. With a greater amount of body fat, the potential conversion of androgens into estrogens may also be higher.
Estradiol performs normal physiological functions in the male body. It contributes to maintaining bone tissue, sexual function, lipid metabolism and nervous system function. The goal, therefore, is not to eliminate estrogen completely, but to maintain an appropriate hormonal balance.
Aromatase on a testosterone cycle and changes in estradiol levels
When exogenous testosterone is used, its concentration in the body rises. As a result, a greater amount of substrate becomes available for aromatase to convert into estradiol.
However, the same amount of testosterone does not necessarily produce the same estradiol level in different people. The outcome is influenced by individual aromatase activity, body-fat percentage, metabolic differences and other compounds being used at the same time.
This is why one athlete may tolerate a higher testosterone level without pronounced estrogen-related symptoms, while another may experience a much more noticeable increase in estradiol.
Testosterone Enanthate
Testosterone Enanthate is a long-ester form of testosterone. Once the hormone is released, the ester does not change the fundamental mechanism of testosterone itself: active testosterone still interacts with androgen receptors and can still be aromatized into estradiol. The main differences between esters concern the rate of release and the duration of changes in hormone concentration.
Dinespower offers Testomed E250, which is based on Testosterone Enanthate. This product provides a practical example of a long-ester testosterone form while preserving the same underlying mechanisms of testosterone action and aromatization.
Testosterone Cypionate
Testosterone Cypionate is also a long-ester form of testosterone. In terms of its basic hormonal action, it is not fundamentally different from other testosterone esters: once the active hormone is released, it can produce androgenic effects and can also be aromatized into estradiol.
On Dinespower, this form is available as Testomed C250. Its active ingredient is Testosterone Cypionate, so its differences from other esters are primarily related to pharmacokinetics rather than to a separate aromatization mechanism.
Testosterone Propionate
Testosterone Propionate uses a shorter ester and is associated with faster changes in active hormone concentrations. Testosterone itself, however, retains its ability to aromatize into estradiol. For this reason, a short ester should not be viewed as a form that automatically solves the problem of elevated estradiol.
Dinespower offers Testomed P100 with Testosterone Propionate. It is a practical example of a short-ester testosterone form in which the same basic mechanisms of androgenic action and aromatization still apply.
If ester blends are used, they are better considered separately from single-ester forms. A blend changes the pharmacokinetic profile, but it does not remove testosterone’s ability to be converted into estradiol.
High estradiol on cycle: causes, signs and effects on the body
High estradiol during a cycle may be associated with a greater amount of aromatizable testosterone, higher individual aromatase activity, a high body-fat percentage or a combination of several factors.
Possible signs include:
- pronounced water retention;
- tenderness or a firm area around the breast tissue;
- changes in libido;
- erectile dysfunction;
- changes in mood or emotional state;
- increased blood pressure associated with overall fluid retention and other contributing factors.
These symptoms are nonspecific. Reduced libido and impaired erectile function, for example, can occur with both high and excessively low estradiol. It is therefore not possible to determine hormone concentration reliably based on symptoms alone.
Gynecomastia also cannot be reduced to a single estradiol value. The duration of exposure, tissue sensitivity and the overall hormonal environment all play a role.
Monitoring and testing estradiol during a cycle
For an athlete, an estradiol test is useful not because of the number itself, but because it helps determine whether the hormonal picture is consistent with the current symptoms and the level of androgen exposure.
If pronounced water retention, breast tenderness, changes in libido or other symptoms appear, relying on subjective sensations alone is not enough. Laboratory testing can help distinguish an actual rise in estradiol from other causes that can produce similar symptoms.
At low estradiol concentrations in men, the testing method also matters. More sensitive laboratory methods can provide a more accurate assessment within the male range, whereas standard immunoassays may be less precise at very low concentrations.
There is no universal rule such as “test after 14 days and then every 6–8 weeks.” The appropriate interval depends on the form of testosterone being used, the stability of the current regimen, changes in the compounds being used and whether symptoms are present.
What affects aromatase activity and estradiol levels?
Estradiol levels are influenced not only by aromatase itself. The amount of available testosterone, body composition and individual physiology are also important.
Relevant factors may include:
- testosterone levels;
- body-fat percentage;
- individual aromatase expression;
- liver function;
- concomitant compounds or medications;
- the overall hormonal environment.
Adipose tissue is one of the important sites of peripheral aromatization. For this reason, excess body weight and a higher amount of body fat may increase the potential for estradiol production. Reducing excess body fat can alter this balance.
If estradiol rises specifically in response to pharmacological use, it is important to understand the cause. In some cases, the issue may be a high level of aromatizable testosterone rather than an automatic need to add another drug.
Aromatase inhibitors in bodybuilding: mechanism of action and use
Aromatase inhibitors reduce the conversion of androgens into estrogens by suppressing the aromatase enzyme. This leads to a reduction in estradiol synthesis.
In sports practice, these compounds are mainly discussed in the context of controlling pronounced aromatization and the estrogen-related effects associated with it. However, the use of testosterone alone does not automatically mean that an aromatase inhibitor is required.
Different aromatase inhibitors also differ in the way they interact with the enzyme.
Anastrozole
Anastrozole is a non-steroidal aromatase inhibitor with a reversible binding mechanism. It reduces estrogen formation by suppressing aromatase activity. In bodybuilding, it is discussed mainly in the context of controlling elevated estradiol, but the need for such intervention should be assessed based on blood tests, symptoms and the overall hormonal picture.
On Dinespower, Anastrozole is available as Arimimed 1. It belongs to the same class of aromatase inhibitors and serves as a practical example of a specific Anastrozole-based product.
Exemestane
Exemestane belongs to the steroidal aromatase inhibitors and acts as an irreversible inactivator of the enzyme. Its mechanism differs from that of Anastrozole and Letrozole, although the final effect is also related to a reduction in estrogen synthesis.
Dinespower offers Exemestane as Aromamed 25. In this article, it serves as a practical example of a steroidal aromatase inhibitor with a mechanism of interaction with the enzyme that differs from that of non-steroidal inhibitors.
Letrozole
Letrozole is a non-steroidal, reversible aromatase inhibitor. It can markedly reduce estrogen production, which makes it particularly important to understand that stronger estradiol suppression does not automatically result in better hormonal balance.
On Dinespower, Letrozole is available as Femamed 2.5. Within this article, it completes the comparison of three major aromatase inhibitors with different pharmacological profiles.
Anastrozole, Exemestane and Letrozole differ in their pharmacological profiles, but none of them should be regarded as a universal addition to every testosterone cycle. Anastrozole and Letrozole are non-steroidal reversible inhibitors, whereas Exemestane is a steroidal irreversible inactivator of aromatase.
Aromatase inhibitors, testosterone and recovery after a cycle
Lowering estradiol reduces estrogen-mediated negative feedback and, in certain clinical situations, may be accompanied by an increase in gonadotropins and endogenous testosterone. However, this effect cannot automatically be applied to recovery after the use of anabolic steroids.
After an AAS cycle, the hypothalamic-pituitary-gonadal axis may be suppressed directly by exogenous androgens. For this reason, an aromatase inhibitor is not a universal method for restoring the body’s own testosterone production.
In bodybuilding, recovery after a cycle is commonly discussed in the context of post-cycle therapy (PCT), but the need for specific drugs depends on the state of the hormonal axis and the results of medical evaluation.
Risks of excessive estradiol suppression and hormonal imbalance
The opposite mistake is also common. Trying to remove as much estradiol as possible can lower the hormone to a level that becomes a problem in itself.
Excessively low estradiol may be associated with:
- reduced libido;
- impaired erectile function;
- poorer overall well-being;
- joint discomfort;
- changes in mood;
- negative effects on bone tissue when severe estrogen deficiency persists over time.
Estradiol contributes to male sexual function and the maintenance of bone tissue, so complete suppression is not a physiological goal.
It is especially important not to identify low estradiol on the basis of a single symptom. Fatigue, reduced libido or poor recovery can have many different causes.
Aromatase in bodybuilding: key takeaways
Aromatase converts testosterone into estradiol, and this process is a normal part of male hormone metabolism. During a testosterone cycle, the amount of substrate available for aromatization increases, so estradiol levels may rise noticeably in some athletes.
The goal, however, is not to suppress aromatase activity or estradiol as much as possible. Both high and excessively low estradiol levels may be associated with unwanted effects.
In practice, it is more useful to assess several factors together: testosterone levels, estradiol levels, the presence of symptoms, body-fat percentage and the compounds being used.
Aromatase inhibitors, including Anastrozole, Exemestane and Letrozole, can indeed reduce estrogen production, but they are not an automatic requirement for every testosterone cycle.
For an athlete, the appropriate approach is not to pursue the lowest possible estradiol level, but to understand how pronounced aromatization is in the individual situation and whether there are real grounds to intervene in hormonal balance.





